Strategic information is everyone’s business: perspectives from an international stakeholder meeting to enhance strategic information data along the HIV Cascade for people who inject drugs

Harm Reduction Journal

Catherine S. Todd¹  Stephen Mills¹  Lisa G. Johnston⁵  Edo Agustian²  Keith Sabin⁴  Jennifer Hegle³  Richard D. Pierce⁶ 

[1] FHI 360 Asia-Pacific Regional Office, 19th floor, Sindhorn Building, 130-132 Wittayu Road, Bangkok 10330, Thailand;Persaudaraan Korban Napza Indonesia (PKNI)/Indonesian Drug User Network, Jalan Tebet Timur Dalam XI No. 94 Tebet, Jakarta Selatan 12820, Indonesia;FHI 360, 359 Blackwell Street, Suite 200, Durham 27701, NC, USA;Joint United Nations Programme on HIV/AIDS (UNAIDS), 20, Avenue Appia, Geneva 27, Switzerland;64 Nieuwezijds Voorburgwal, Amsterdam SC1012, Netherlands;85 Sukhumvit Soi 13, #5B, Bangkok, Thailand

关键词: HIV Cascade;    Intervention;    Key populations;    Strategic information;    Harm reduction;    HIV;    People who inject drugs;   

Others  :  1230025
DOI  :  10.1186/s12954-015-0073-y

 received in 2015-06-04, accepted in 2015-09-12,  发布年份 2015

【 摘 要 】

People who inject drugs (PWID) are at increased HIV transmission risk because of unsafe injecting practices and a host of other individual, network, and structural factors. Thus, PWID have a great need for services within the Cascade of HIV prevention, diagnosis, care, and treatment (HIV Cascade). Yet the systems that monitor their progress through the Cascade are often lacking. Subsequently, fewer reliable data are available to guide programs targeting this key population (KP). Programmatic data, which are helpful in tracking PWID through the Cascade, also are limited because not all countries have harm reduction programming from which to estimate Cascade indicators. Also, due to stigma and the illegal nature of drug use, PWID may not disclose their drug use behavior or HIV status when accessing services. Consequently, PWID appear to have low HIV testing rates and, for those living with HIV, lower access to health services and lower viral suppression rates than do other KP groups. This commentary, based on outcomes from an international stakeholder meeting, identifies data gaps and proposes solutions to strengthen strategic information (SI), the systematic collection, analysis, and dissemination of information, to optimize HIV prevention, care, and treatment programming for PWID.

【 授权许可】

   
2015 Pierce et al.

【 参考文献 】

• [1]Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2005; 61(5):1026-44.
• [2]Gyarmathy VA, Caplinskiene I, Caplinskas S, Latkin CA. Social network structure and HIV infection among injecting drug users in Lithuania: gatekeepers as bridges of infection. AIDS Behav. 2014; 18(3):505-10.
• [3]Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R et al.. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010; 376(9737):268-84.
• [4]Chakrapani V, Velayudham J, Shunmugam M, Newman PA, Dubrow R. Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India. AIDS Care. 2014; 26(7):835-41.
• [5]Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010; 376(9738):355-66.
• [6]Joint United Nations Programme on HIV/AIDS (UNAIDS). The Gap Report. UNAIDS, July 2014, Geneva. http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf. Accessed 23 July 2015.
• [7]90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS, Geneva; 2014.
• [8]FHI360. Project: Linkages across the Continuum of HIV Services for Key Populations Affected by HIV (LINKAGES). http://www.fhi360.org/projects/linkages-across-continuum-hiv-services-key-populations-affected-hiv-linkages. Accessed 2 June 2015.
• [9]UNAIDS. AIDSInfo Online. http://www.aidsinfoonline.org/devinfo/libraries/aspx/Home.aspx. Accessed 2 June 2015.
• [10]Syvertsen JL, Agot K, Ohaga S, Strathdee SA, Camlin CS, Omanga E, Odonde P, Rota G, Akoth K, Peng J, Wagner KD. Evidence of injection drug use in Kisumu, Kenya: implications for HIV prevention. Drug Alcohol Depend. 2015; 151:262-6.
• [11]The Global State of Harm Reduction. International Harm Reduction Association, London; 2014.
• [12]Guidelines for second generation HIV surveillance. An update: know your epidemic. WHO, Geneva; 2013.
• [13]Johnston LG, McFarland W, Sabin ML, Prybylski D, Sabin KM, Baral S et al.. Measuring self-reported HIV status in bio-behavioural surveys. Bull World Health Organ. 2015; 93:287-287A.
• [14]FHI360. Fansipan Challenge. http://www.fhi360.org/media/videos/fansipan-challenge. Accessed 25 May 2015.